Archive for January 7th, 2018

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

07-Jan-2018 Intellasia | BusinessWire | 9:25 PM

SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Harbour BioMed announced today that it has licensed its patented H2L2 transgenic [...]
» More